Association Between Cancer Genes and Germ Layer Specificity

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2022 Sep 29

PMID 36175592

Authors

Hwayeong Lee

Sungwhan Lee

Woo Jong Cho

Minjung Shin

Leeyoung Park

Affiliations

Soon will be listed here.

Abstract

Cancer signaling pathways defining cell fates are related to differentiation. During the developmental process, three germ layers (endoderm, mesoderm, and ectoderm) are formed during embryonic development that differentiate into organs via the epigenetic regulation of specific genes. To examine the relationship, the specificities of cancer gene mutations that depend on the germ layers are studied. The major organs affected by cancer were determined based on statistics from the National Cancer Information Center of Korea, and were grouped according to their germ layer origins. Then, the gene mutation frequencies were evaluated to identify any bias based on the differentiation group using the Catalogue of Somatic Mutations in Cancer (COSMIC) database. The chi-square test showed that the p-value of 152 of 166 genes was less than 0.05, and 151 genes showed p-values of less than 0.05 even after adjusting for the false discovery rate (FDR). The germ layer-specific genes were evaluated using visualization based on basic statistics, and the results matched the top ranking genes depending on organs in the COSMIC database.The current study confirmed the germ layer specificity of major cancer genes. The germ layer specificity of mutated driver genes is possibly important in cancer treatments because each mutated gene may react differently depending on the germ layer of origin. By understanding the mechanism of gene mutation in the development and progression of cancer in the context of cell-fate pathways, a more effective therapeutic strategy for cancer can be established.

References

Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

Stratton M, Campbell P, Futreal P . The cancer genome. Nature. 2009; 458(7239):719-24. PMC: 2821689. DOI: 10.1038/nature07943. View

Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

Kandoth C, McLellan M, Vandin F, Ye K, Niu B, Lu C . Mutational landscape and significance across 12 major cancer types. Nature. 2013; 502(7471):333-339. PMC: 3927368. DOI: 10.1038/nature12634. View

Hoadley K, Yau C, Hinoue T, Wolf D, Lazar A, Drill E . Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018; 173(2):291-304.e6. PMC: 5957518. DOI: 10.1016/j.cell.2018.03.022. View

Hanahan D . Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022; 12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Martin G . Cell signaling and cancer. Cancer Cell. 2003; 4(3):167-74. DOI: 10.1016/s1535-6108(03)00216-2. View

Thisse B, Thisse C . Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol. 2005; 287(2):390-402. DOI: 10.1016/j.ydbio.2005.09.011. View

10.

Logan C, Nusse R . The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20:781-810. DOI: 10.1146/annurev.cellbio.20.010403.113126. View

11.

Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, Hassan A . Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A. 2003; 100(6):3299-304. PMC: 152286. DOI: 10.1073/pnas.0434590100. View

12.

Sell S . Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004; 51(1):1-28. DOI: 10.1016/j.critrevonc.2004.04.007. View

13.

Jiang J, Hui C . Hedgehog signaling in development and cancer. Dev Cell. 2008; 15(6):801-12. PMC: 6443374. DOI: 10.1016/j.devcel.2008.11.010. View

14.

Gregorieff A, Clevers H . Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005; 19(8):877-90. DOI: 10.1101/gad.1295405. View

15.

Bolos V, Grego-Bessa J, de la Pompa J . Notch signaling in development and cancer. Endocr Rev. 2007; 28(3):339-63. DOI: 10.1210/er.2006-0046. View

16.

Hao X, Luo H, Krawczyk M, Wei W, Wang W, Wang J . DNA methylation markers for diagnosis and prognosis of common cancers. Proc Natl Acad Sci U S A. 2017; 114(28):7414-7419. PMC: 5514741. DOI: 10.1073/pnas.1703577114. View

17.

Shi M, Tsui S, Wu H, Wei Y . Pan-cancer analysis of differential DNA methylation patterns. BMC Med Genomics. 2020; 13(Suppl 10):154. PMC: 7579968. DOI: 10.1186/s12920-020-00780-3. View

18.

Zhang J, Huang K . Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers. BMC Genomics. 2017; 18(Suppl 1):1045. PMC: 5310283. DOI: 10.1186/s12864-016-3259-0. View

19.

Locke W, Guanzon D, Ma C, Liew Y, Duesing K, Fung K . DNA Methylation Cancer Biomarkers: Translation to the Clinic. Front Genet. 2019; 10:1150. PMC: 6870840. DOI: 10.3389/fgene.2019.01150. View

20.

Yang X, Gao L, Zhang S . Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Brief Bioinform. 2016; 18(5):761-773. DOI: 10.1093/bib/bbw063. View